ArriVent BioPharma, Inc. 8-K

Accession 0001104659-25-108839

Filing information

CIK: 0001868279
Report date: 2025-11-10
Filing date: 2025-11-10
Form: 8-K
Primary document: avbp-20251110x8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.